NCT04648033 2026-01-29
ARCADIAN
University of Oxford
Phase 1 Completed
Clinical Trials
5 trialsNCT03568994 2026-01-27
ATACC AML
Baylor College of Medicine
Phase EARLY_PHASE1 Completed
NCT05998135 2025-09-11
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Emory University
Phase 2 Recruiting
NCT06624371 2025-07-22
AflacBT2303
Emory University
Phase 1 Recruiting
NCT02628080 2019-09-04
ATOM
University of Oxford
Phase EARLY_PHASE1 Completed